SCHEMBL360499

SCHEMBL360499

Fc1ccc(N(c2ncccc2Cl)[C@H]2CCNC2)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 7/20 0.39
SLC6A4 P31645 6/20 0.39
SLC6A3 Q01959 5/20 0.39
CYP2D6 P10635 2/20 0.39
KCNH2 Q12809 7/20 0.39
RPLP1 P05386 6/20 0.39
RPLP0 P05388 6/20 0.39
RPS17 P08708 6/20 0.39
RPSA P08865 6/20 0.39
RPS2 P15880 6/20 0.39
RPL35A P18077 6/20 0.39
RPL7 P18124 6/20 0.39
RPL17 P18621 6/20 0.39
RPS4Y1 P22090 6/20 0.39
RPS3 P23396 6/20 0.39
RPS12 P25398 6/20 0.39
RPL13 P26373 6/20 0.39
RPL10 P27635 6/20 0.39
RPL12 P30050 6/20 0.39
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 6/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4769714 0.84 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL330261 0.84 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL4768112 0.82 CYP3A4 (0.45)
SCHEMBL330236 0.82 CYP3A4 (0.45)
SCHEMBL330631 0.79 TACR1 (0.37) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL330630 0.79 TACR1 (0.37) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL330952 0.79 TACR1 (0.35) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL330350 0.79 TACR1 (0.35) SLC6A2SLC6A4SLC6A3CYP2D6TACR1
SCHEMBL330351 0.79 TACR1 (0.35) SLC6A2SLC6A4SLC6A3CYP2D6TACR1
SCHEMBL330622 0.78 TACR1 (0.36) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2407451-A1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors Otsuka Pharmaceutical Co., Ltd. (JP) 2012-01-18 EP disclosed